Skip to contentC
China Pharma Holdings, Inc.
C
CPHIChina Pharma Holdings, Inc. Q1 2016 · 10-Q
Revenue$3.64M$3.64M−36.1% vs Q1 2015 Net Income-$1.55M-$1.55MN/M vs Q1 2015 EPS Diluted-$0.04-$0.04N/M vs Q1 2015 Gross Profit$640,819−39.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
Operating Cash Flow$1,303,202N/M Free Cash Flowderived$1,263,954N/M Margins · derivedGross margin17.6%−1.0 pt vs Q1 2015
Operating margin-36.3%+29.8 pt vs Q1 2015
Net margin-42.7%+28.8 pt vs Q1 2015
ended Mar 31, 2016 · filed May 16, 2016 · 46 d after period end